Xcout Intel
Catalio Capital Management
Catalio Capital Management, LP is a New York-headquartered investment firm founded by George Petrocheilos and Dr. Jacob Vogelstein that specializes in investing in breakthrough biomedical and life science companies.
Subscribe to see Catalio Capital Management’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Catalio Capital Management at a glance
Catalio Capital Management is a company headquartered in United States. Xcout tracks 12 named people at Catalio Capital Management, including Henry Kravis (Chairman).
Catalio Capital Management leadership
- Henry KravisChairman
- George C. PetrocheilosCo-Founder & Managing Partner
- R. Jacob Vogelstein, Ph.D.Co-Founder & Managing Partner
- Alex GorskyMember, Board of Advisors
- Glenn DubinMember, Board of Advisors
- Isabelle EaletMember, Board of Advisors
6 more named people on record for Catalio Capital Management, with roles, board committees and tenure — see the full roster →
Catalio Capital Management competitors
A few of Catalio Capital Management's closest competitors — see the full list of competitors and alternatives →
TCG Crossover (TCGX) is an investment firm with offices in Palo Alto and New York, focused on financing innovative private and public biotech companies building the future of medicine.
Commodore Capital is an investment firm that focuses on funding smaller, innovative biopharmaceutical companies. The firm supports the development of novel therapeutic modalities, such as genetic medicines and cellular therapies, to help bring new treatments to patients.
EGB Ventures is a physician-led venture formation family office that creates, finances, and develops biotechnology companies focused on clinically validated therapeutic opportunities and significant unmet medical needs. The firm identifies breakthrough science, structures new ventures, recruits management teams, and guides strategic development from pre-clinical stages onward.
New Science Ventures is a New York-based venture capital firm that invests primarily in early-stage companies developing innovative technologies in life sciences and related scientific fields. It supports entrepreneurs and research-driven startups, including biotechnology, medical devices, and healthcare technology companies.
RA Capital Management is an investment management firm focused on public and private investments in life sciences and healthcare companies, including biotechnology, pharmaceuticals, medical devices, and diagnostics. It manages capital for institutional and other qualified investors while supporting emerging healthcare companies through financing and strategic expertise.
Catalysis Capital is an independent specialist advisory boutique that provides strategic and financial guidance exclusively to the life sciences sector. The firm serves innovators, executives, entrepreneurs, and investors by acting as a deal-catalyst with dedicated senior-level attention.
Get Catalio Capital Management's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Catalio Capital Management? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Catalio Capital Management in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access